• Home
  • About us
  • Log-In
  • Join Us
  • Sitemap
  • Recruit
Á¦Ç°/½ÇÇè Q&A
ÀÚÁÖ¹¯´ÂÁú¹®
ÀÚÀ¯°Ô½ÃÆÇ
½ÇÇè±â¹ý
ÀÚ·á½Åû
³í¹®ÀÚ·á
Ŭ·¹ÀÓ Á¢¼ö
±â±â A/S Á¢¼ö
Ŭ·¹ÀÓ ÁøÇàÁ¶È¸
 Á¦Ç°¾È³»  ¸ÂÃã ¼­ºñ½º   Drug Discovery Service

Cardiac Profiler ¼­ºñ½º

°í°´²²¼­ °³¹ßÇϽŠhit or lead compoundsÀÇ Cardiac Ion Channel Selectivity Screening ¼­ºñ½º¸¦ Á¦°øÇØ µå¸³´Ï´Ù.

Merck Millipore
Á¦Ç° ¹®ÀÇÇϱâ
ÀμâÇϱâ
    Ư¡
  • °í°´²²¼­ °³¹ßÇÑ ½Å¾àÀÌ ½ÉÀåÀÇ ¸®µëÀ» Á¶ÀýÇÏ´Â ion channel¿¡ ´ëÇØ ¾ó¸¶³ª ¾ÈÁ¤ÇÑÁö¸¦ Å×½ºÆ® ÇØµå¸³´Ï´Ù.
  • ¹Ð¸®Æ÷¾Æ¿¡¼­ Á¦ÀÛÇÑ PrecisION hERG cell lineÀ» ÀÌ¿ëÇÏ¿© ½ÇÇèÇØ µå¸³´Ï´Ù.
  • ¸íÈ®Çϰí Á¤È®ÇÑ Profiling data¸¦ Á¦°øÇÕ´Ï´Ù.
  • »ùÇà ÀÇ·Ú¿¡¼­ °á°ú¹° È®ÀαîÁö 2ÁÖÀÏÁ¤µµ ¼Ò¿äµË´Ï´Ù.
    ¼­ºñ½º ¹æ¹ý
  1. 1. ¾Æ·¡ÀÇ 3°¡Áö Á¶°ÇÀ» °í¸¶¿¡ Á¦°øÇØ ÁÖ¼Å¾ß ÇÕ´Ï´Ù.
    1. 1) Å×½ºÆ®¸¦ ¿øÇÏ´Â compoundÀÇ °¹¼ö
    2. 2) Å×½ºÆ®¸¦ ¿øÇÏ´Â [compound] ³óµµ¼ö
    3. 3) Å×½ºÆ®¸¦ ¿øÇÏ´Â hERG Ion channelÀÇ Á¾·ù
    4. * Å×½ºÆ® ¹Ýº¹È½¼ö´Â Áߺ¹½ÇÇèÀ» ±âº»»ç¾çÀ¸·Î ÇÕ´Ï´Ù.
  2. 2. °í¸¶·ÎºÎÅÍ °ßÀûÀ» ¹ÞÀ¸½ÅÈÄ compound shipping information°ú ÇÔ²² compound¸¦ °í¸¶·Î ¹ß¼ÛÇÕ´Ï´Ù.
    ½Ã·á º¸³»½Ç°÷
  • ÁÖ¼Ò: (¿ì:157-793) ¼­¿ï½Ã °­¼­±¸ °¡¾ç3µ¿1487¹øÁö °¡¾çÅ×Å©³ëŸ¿î 301È£ °í¸¶¹ÙÀÌ¿ÀÅØ(ÁÖ)
  • ÀüÈ­: 02-579-8787, ÆÑ½º : 02-578-7042
  • À̸ÞÀϹ®ÀÇ: koma@komabiotech.co.kr
    CardiacProfiler Á¾·ù
    Description Catalogue Number
    hERG CardiacProfiler IW Service CYL6038QU
    In vitro testing of compounds for hERG (IKr) block is an essential component in assessing cardiac risk. Functional assay using automated electrophysiology (IonWorks)
    hERG CardiacProfiler PX Service CYL6039PX
    In vitro testing of compounds for hERG (IKr) block is an essential component in assessing cardiac risk. Functional assay using automated electrophysiology (PatchXpress)
    hKCNQ1/hminK CardiacProfiler Service CYL5007QU
    Potassium channel mediating IKs current that is involved in action potential repolarization in ventricular cardiac myocytes. Functional assay using automated electrophysiology (IonWorks)
    hHCN4 CardiacProfiler Service CYL5012HT
    An ion channel giving rise to the hyperpolarization activated current (Ih) that maintains the resting potential of ventricular cardiac myocytes. Functional assay using automated electrophysiology (IonWorks)
    hKv4.3/hKChIP2 CardiacProfiler Service CYL5069QU
    Potassium channel underlying IKto current that is involved in the early repolarization phase of action potentials in ventricular cardiac myocytes. Functional assay using automated electrophysiology (IonWorks)
    hNav1.5 CardiacProfiler IW Service CYL5004QU
    The sodium channel mediating INa, the current that initiates the cardiac action potential in ventricular myocytes. Functional assay using automated electrophysiology (IonWorks)
    hNav1.5 CardiacProfiler PX Service CYL5004PX
    The sodium channel mediating INa, the current that initiates the cardiac action potential in ventricular myocytes. Functional assay using automated electrophysiology (PatchXpress).
    hKv1.5 CardiacProfiler Service CYL5018QU
    Potassium channel mediating IKur current that is involved in repolarizing action potentials in atrial cardiac myocytes. Functional assay using automated electrophysiology (IonWorks)
    Human L-type Calcium Channel CardiacProfiler Service CYL5051QU
    The calcium channel (Cav1.2) mediating ICa current that maintains the plateau phase of the action potential in ventricular cardiac myocytes. Functional assay using automated electrophysiology (IonWorks)
    hKir2.1 CardiacProfiler Service CYL5032QU
    An ion channel giving rise to a leak activated current that maintains the resting potential of ventricular cardiac myocytes. Functional assay using automated electrophysiology (IonWorks)
    Ion Channel CardiacProfiler Panel Service: CYL9000
    The Ion Channel CardiacProfiler Panel Service is offered as a monthly profiling service that allows for the comprehensive functional assessment of drug candidates against hERG, hKCNQ1/hminK, hKv1.5, hNav1.5, hHCN4, hKv4.3/hKChIP2, Human L-type Calcium and hKir2.1 ion channels. Collectively, these cardiac ion channels play a critical role in the normal functioning of the human heart and were chosen to provide a more thorough assessment of the true cardiac liability of drug candidates. The potential for altered function to cause QT prolongation has been implicated for the majority of these channels by the occurrence of human LQT mutations. The Ion Channel CardiacProfiler Panel Service utilizes eight distinct PrecisION ion channel cell lines corresponding to each of these cardiac ion channels. All of these cell lines were optimized for use on the IonWorks automated patch clamp instrument for this service.